Filtered By:
Condition: Patent Foramen Ovale

This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 1415 results found since Jan 2013.

PFO morphology for evaluation of c-TCD and c-TTE RLS grades
ConclusionsStudies have shown that the morphological structure of PFO is an influencing factor of RLS, and TEE can observe the specific morphological characteristics of PFO, which can further predict the level of RLS, help predict the occurrence of Cryptogenic stroke (CS). The above provides more evidences and surgical options for Interventional device closure indications.
Source: European Journal of Medical Research - November 3, 2022 Category: Research Source Type: research

Transcranial Doppler for stratification of high-risk morphology of patent foramen ovale in patients with cryptogenic stroke
In conclusion, the existence of a large HITS detected by TCD may have a screening advantage in predicting the high-risk morphologies of PFO that can cause paradoxical cerebral embolism.
Source: Heart and Vessels - November 1, 2022 Category: Cardiology Source Type: research

Effect of atrial septal dilation tumor and patent foramen rotundus on cryptogenic ischemic stroke in young and middle-aged patients
Conclusion: Atrial septal aneurysm combined with PFO and PFO are independent influencing factors factor for the occurrence of cryptogenic ischemic stroke in young and middle-aged people, which is worthy of further study.Keywords: Atrial septal aneurysm; Cryptogenic ischemic stroke; Influencing factors; Patent foramen ovale; Young and middle-aged.
Source: African Health Sciences - October 28, 2022 Category: African Health Authors: Tengtao Ling, Dongxing Xie Source Type: research

The Hype Surrounding Patent Foramen Ovale Closure and Cryptogenic Stroke: A Walk Through History
This article is the first of a multi-part review and will detail the history of PFO closure and the clinical trials that have evaluated the efficacy of PFO device closure. Data favour PFO closure in CS for reducing stroke in appropriate patients and should be considered as a treatment modality.PMID:36275353 | PMC:PMC9524620 | DOI:10.17925/HI.2022.16.1.59
Source: Heart International - October 24, 2022 Category: Cardiology Authors: Lekha Racharla Akhil Kher Zeel Patel Theresa Maitz Bryan Kluck Source Type: research